Neogen (NEOG) FCF Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neogen | 1.94 Bn | 1.78 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 242.00 |
| Nov 30, 2025 | -1,006.00 |
| Aug 31, 2025 | -2,539.00 |
| May 31, 2025 | -1,625.00 |
| Feb 28, 2025 | -2,237.00 |
| Nov 30, 2024 | 33.00 |
| Aug 31, 2024 | -4,298.00 |
| May 31, 2024 | -1,543.00 |
| Feb 29, 2024 | -3,259.00 |
| Nov 30, 2023 | -1,471.00 |
| Aug 31, 2023 | -1,755.00 |
| May 31, 2023 | 1,051.00 |
| Feb 28, 2023 | -2,876.00 |
| Nov 30, 2022 | -1,613.00 |
| Aug 31, 2022 | -3,564.00 |
| May 31, 2022 | -806.00 |
| Feb 28, 2022 | -1,009.00 |
| Nov 30, 2021 | 223.00 |
| Aug 31, 2021 | -13,055.00 |
| May 31, 2021 | 679.00 |
| Feb 28, 2021 | -216.00 |
| Nov 30, 2020 | 188.00 |
| Aug 31, 2020 | 1,406.00 |
| May 31, 2020 | 679.00 |
| Feb 29, 2020 | 466.00 |
| Nov 30, 2019 | -604.00 |
| Aug 31, 2019 | 530.00 |
| May 31, 2019 | 1,602.00 |
| Feb 28, 2019 | -42.00 |
| Nov 30, 2018 | 627.00 |
| Aug 31, 2018 | 830.00 |
| May 31, 2018 | 809.00 |
| Feb 28, 2018 | 429.00 |
| Nov 30, 2017 | -800.00 |
| Aug 31, 2017 | 1,006.00 |
| May 31, 2017 | -168.00 |
| Feb 28, 2017 | -140.00 |
| Nov 30, 2016 | 228.00 |
| Aug 31, 2016 | 15,962.00 |
| May 31, 2016 | -89.00 |
| Feb 29, 2016 | -87.00 |
| Nov 30, 2015 | -239.00 |
| Aug 31, 2015 | -1,818.00 |